National Center for Health Statistics. U.S. Overdose Deaths Decrease in 2023, First Time Since 2018: Centers for Disease Control and Prevention; 2024 [Available from: https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2024/20240515.htm

Delphin-Rittmon ME, The National Survey on Drug Use and Health.: 2020 2022 [Available from: https://www.samhsa.gov/data/sites/default/files/reports/slides-2020-nsduh/2020NSDUHNationalSlides072522.pdf

Office of National Drug Control Policy. National Drug Control Strategy: The White House; 2022 [Available from: https://www.whitehouse.gov/wp-content/uploads/2022/09/2022-National-Interdiction-Command-and-Control-Plan-NICCP.pdf

Dallery J, Defulio A, Raiff BR. Digital contingency management in the treatment of substance use disorders. Policy Insights Behav Brain Sci. 2023;10:51–8.

Article  Google Scholar 

Pew Research Center. Mobile Fact Sheet 2021 [Available from: https://www.pewresearch.org/internet/fact-sheet/mobile/

Hsu M, Martin B, Ahmed S, Torous J, Suzuki J, Smartphone, Ownership. Smartphone utilization, and interest in using mental health apps to address substance use disorders: literature review and Cross-sectional survey study across two sites. JMIR Form Res. 2022;6(7):e38684.

Ashford RD, Lynch K, Curtis B. Technology and social media use among patients enrolled in outpatient addiction treatment programs: Cross-Sectional survey study. J Med Internet Res. 2018;20(3):e84.

Article  PubMed  PubMed Central  Google Scholar 

Masson CL, Chen IQ, Levine JA, Shopshire MS, Sorensen JL. Health-related internet use among opioid treatment patients. Addict Behav Rep. 2019.

Wang Y, Min J, Khuri J, Xue H, Xie B, L AK et al. Effectiveness of mobile health interventions on diabetes and obesity treatment and management: systematic review of systematic reviews. JMIR Mhealth Uhealth. 2020;8(4).

Hamine S, Gerth-Guyette E, Faulx D, Green BB, Ginsburg AS. Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review. J Med Internet Res. 2015;17(2).

Bricker JB, Watson NL, Mull KE, Sullivan BM, Heffner JL. Efficacy of smartphone applications for smoking cessation: A randomized clinical trial. JAMA Intern Med. 2020;180(11):1472–80.

Article  PubMed  Google Scholar 

Hoeppner BB, Schick MR, Kelly LM, Hoeppner SS, Bergman B, Kelly JF. There is an app for that - Or is there? A content analysis of publicly available smartphone apps for managing alcohol use. J Subst Abuse Treat. 2017;82:67–73.

Article  PubMed  Google Scholar 

Bosse JD, Hoffman K, Wiest K, Todd Korthuis P, Petluri R, Pertl K, et al. Patient evaluation of a smartphone application for telehealth care of opioid use disorder. Addict Sci Clin Pract. 2022;17:50.

Article  PubMed  PubMed Central  Google Scholar 

Hodges J, Waselewski M, Harrington W, Franklin T, Schorling K, Huynh J et al. Six-month outcomes of the HOPE smartphone application designed to support treatment with medications for opioid use disorder and piloted during an early statewide COVID-19 lockdown. Addict Sci Clin Pract. 2022;17.

Magee MR, McNeilage AG, Avery N, Glare P, Ashton-James CE. mHealth Interventions to Support Prescription Opioid Tapering in Patients With Chronic Pain: Qualitative Study of Patients’ Perspectives. JMIR Form Res. 2021;5(5).

Proctor SL, Rigg KK, Tien AY. Acceptability and usability of a Reward-Based mobile app for opioid treatment settings: mixed methods pilot study. JMIR Form Res. 2022;6(10):e37474.

Article  PubMed  PubMed Central  Google Scholar 

Scherzer CR, Ranney ML, Patena J, Jennings E, Langdon KJ, Beaudoin FL. Peer support for opioid use disorder: feasibility and acceptability of a moderate Text-Based group chat application. J Addict Res Ther. 2021;12(3):421.

Google Scholar 

Waselewski ME, Flickinger TE, Canan C, Harrington W, Franklin T, Otero KN, et al. A mobile health app to support patients receiving Medication-Assisted treatment for opioid use disorder: development and feasibility study. JMIR Form Res. 2021;5(2):e24561.

Article  PubMed  PubMed Central  Google Scholar 

Gustafson DH, McTavish FM, Ming-Yuan C, Atwood AK, Johnson RA, Boyle MG, et al. A smartphone application to support recovery from alcoholism: a randomized clinical trial. JAMA Psychiatry. 2014;71(5):566–72.

Article  PubMed  PubMed Central  Google Scholar 

Campbell ANC, Nunes EV, Matthews AG, Stitzer M, Miele GM, Polsky D, et al. Internet-Delivered treatment for substance abuse: A multisite randomized controlled trial. Am J Psychiatry. 2014;171:683–90.

Article  PubMed  PubMed Central  Google Scholar 

Christensen DR, Marsch LA, Chopra MP, Landes RD, Jackson L, Mancino MJ, et al. Adding an Internet-Delivered treatment to an efficacious treatment package for opioid dependence. J Consult Clin Psychol. 2014;82:964–72.

Article  PubMed  PubMed Central  Google Scholar 

Thompson RG, Bollinger M, Mancino MJ, Hasin D, Han X, Bush KA et al. Smartphone intervention to optimize medication-assisted treatment outcomes for opioid use disorder: study protocol for a randomized controlled trial. Trials. 2023;24.

Nuamah J, Mehta R, Sasangohar F. Technologies for opioid use disorder management: mobile app search and scoping review. JMIR Mhealth Uhealth. 2020;8(6).

Haffey F, Brady RR, Maxwell S. A comparison of the reliability of smartphone apps for opioid conversion. Drug Saf. 2013;36(2):111–7.

Article  PubMed  Google Scholar 

Tofighi B, Chemi C, Ruiz-Valcarcel J, Hein P, Hu L. Smartphone apps targeting alcohol and illicit substance use: systematic search in in commercial app stores and critical content analysis. JMIR Mhealth Uhealth. 2019;7(4).

Vilardaga R, Fisher T, Palenski PE, Kumaresan V, Mannelli P, Sweitzer MM, et al. Review of popularity and quality standards of Opioid-Related smartphone apps. Curr Addict Rep. 2020;7(4):486–96.

Article  PubMed  PubMed Central  Google Scholar 

Wallace LS, Dhingra LK. A systematic review of smartphone applications for chronic pain available for download in the united States. J Opioid Manag. 2014;10(1):63–8.

Article  PubMed  Google Scholar 

Dean B. We analyzed 4 million Google Search Results Here’s What We Learned About Organic Click Through Rate backlinko.com: BACKLINKO; 2024 [Available from: https://backlinko.com/google-ctr-stats

Bigabid. Key 2023 Apple App Store vs Google Play Store Differences for Developers and Marketers Bigabid.com: Bigabid; 2023 [Available from: https://www.bigabid.com/apple-app-store-vs-google-play-store-differences/#:~:text=The%20biggest%20advantage%20of%20the,starting%20with%20the%20publishing%20process

Pew Research Center. Mobile Fact Sheet pewresearch.org: Pew Research Center. 2024 [Available from: https://www.pewresearch.org/internet/fact-sheet/mobile/

Hansen WB, Scheier LM. Specialized smartphone intervention apps: review of 2014 to 2018 NIH funded grants. JMIR Mhealth Uhealth. 2019;7(7):e14655.

Article  PubMed  PubMed Central  Google Scholar 

Shaver J. The state of telehealth before and after the COVID-19 pandemic. Prim Care. 2022;49(4):517–30.

Article  PubMed  PubMed Central  Google Scholar 

Molfenter T, Roget N, Chaple M, Behlman S, Cody O, Hartzler B, et al. Use of telehealth in substance use disorder services during and after COVID-19: online survey study. JMIR Mental Health. 2021;8(2):e25835.

Article  PubMed  PubMed Central  Google Scholar 

Desilver D. As it turns 6, a look at who uses the iPhone (no, not everybody) Pewresearch.org: Pew Research Center; 2013 [Available from: https://www.pewresearch.org/short-reads/2013/06/29/as-it-turns-6-a-look-at-who-uses-the-iphone-no-not-everybody/

Lippold KM, Jones CM, Olsen EOM, Giroir BP. Racial/ethnic and age group differences in opioid and synthetic opioid–involved overdose deaths among adults aged ≥ 18 years in metropolitan areas—United States, 2015–2017. MMWR Morb Mortal Wkly Rep. 2019;68:967–73.

Article  PubMed  PubMed Central  Google Scholar 

Friedman JR, Hansen H. Evaluation of increases in drug overdose mortality rates in the US by race and ethnicity before and during the COVID-19 pandemic. JAMA Psychiatry. 2022;79:379–81.

Article  PubMed  PubMed Central  Google Scholar 

Ford IIJH, AE, Dinauer S, Johnson KA, Pe-Romashko K, Gustafson DH. Successful organizational strategies to sustain use of A-CHESS: A mobile intervention for individuals with alcohol use disorders. J Med Internet Res. 2015;17(8).

Pham Q, Wiljer D, Cafazzo JA. Beyond the randomized controlled trial: A review of alternatives in mHealth clinical trial methods. JMIR Mhealth Uhealth. 2016;4(3):e107.

Article  PubMed  PubMed Central  Google Scholar 

Yaroslav Titenok. How Long Does it Take to Build an App in 2024: Development Time and Expert Tips sloboda-studio.com: Sloboda Studio; 2024 [Available from: https://sloboda-studio.com/blog/how-long-does-it-take-to-make-an-app/#:~:text=Average%20mobile%20app%20development%20time%20can%20take%206%20to%209%20months.%26;text=However%2C%20as%20practice%20shows%2C%20each,average%20at%20various%20project%20stages

Volkow ND, Collins FS. The role of science in addressing the opioid crisis. N Engl J Med. 2017;377(4):391–4.

Article  PubMed  Google Scholar 

Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY. Injectable Naltrexone, oral Naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a united States commercially insured population. J Subst Abuse Treat. 2018;85:90–6.

Article  PubMed  Google Scholar 

Hadland SE, Wharam FJ, Schuster MA, Zhang F, Samet JH, Larochelle MR. Trends in receipt of buprenorphine and Naltrexone for opioid use disorder among adolescents and young adults, 2001–2014. JAMA Pediatr. 2017;171(8):747–55.

Article  PubMed  PubMed Central  Google Scholar 

Morgan JR, Walley AY, Murphy SM, Chatterjee A, Hadland SE, Barocas J et al. Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative united States commercially insured cohort. Drug Alcohol Depend. 2021:108764.

Garland E, Hanley AW, Kline A, Cooperman NA. Mindfulness-Oriented recovery enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: ecological momentary assessments from a stage 1 randomized controlled trial. Drug Alcohol Depend. 2019;203:61–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cooperman NA, Hanley AW, Kline A, Garland EL. A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: impact on illicit drug use, health, and well-being. J Subst Use Addict Treat. 2021;127.

Zullig KJ, Lander LR, Sloan S, Brumage MR, Hobbs GR, Faulkenberry L. Mindfulness-based relapse prevention with individuals receiving medication-assisted outpatient treatment for opioid use disorder. Mindfulness. 2018;9(2):423–9.

Article  Google Scholar 

Krentzman AR, Hoeppner BB, Hoeppner SS, Barnett NP. Development, feasibility, acceptability, and impact of positive psychology journaling intervention to support addiction recovery. J Posit Psychol. 2023;18(2):573–91.

Article  Google Scholar 

Mondal J, Chakrabarti S. The abandonment behaviour of the branded app consumer: A study using interpretive structural modelling approach. J Retailing Consumer Serv. 2021;63.

Murnane EL, Huffaker D, Kossinets G. Mobile health apps: adoption, adherence, and abandonment. Adjunct Proceedings of the 2015 ACM International Joint Conference on Pervasive and Ubiquitous Computing and Proceedings of the 2015 ACM International Symposium on Wearable Computers; Osaka, Japan: Association for Computing Machinery; 2015. pp. 261–4.

Hoeppner BB, Hoeppner SS, Seaboyer L, Schick MR, Wu GW, Bergman BG, et al. How smart are smartpho